Skip to content

King Pharmaceuticals KG North America — Net premiums written

Other geography segments

Other (predominantly Europe)
$6.29M

Similar metrics at other companies

Arch Capital Group logo
ACGLNorth America — Net premiums written
$1.43B+17.6%
American International Group logo
AIGNorth America Commercial — Net Premiums Written
$1.61B+36.7%
Chubb logo
CBNorth America Agricultural Insurance — Net premiums written
$311M+12.7%
Chubb logo
CBNorth America Commercial P&C Insurance — Net premiums written
$4.9B+2.3%
Chubb logo
CBNorth American Personal P&C Insurance — Net premiums written
$1.68B+8.3%
Arch Capital Group logo
ACGLNorth America — Net premiums earned
$1.43B+22.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's north america — net premiums written.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's north america — net premiums written?
King Pharmaceuticals (KG) reported north america — net premiums written of -$20K in Q4 2025.
What does north america — net premiums written mean?
Net premiums written reflects the portion of gross premiums retained by the North American segment after accounting for premiums ceded to reinsurers. This metric provides insight into the segment's risk retention strategy and the actual volume of business the company chooses to keep on its own balance sheet. It is a critical measure for evaluating the segment's underwriting appetite and the effectiveness of its reinsurance risk transfer programs.